The baseline characteristics encompassed age, sex, body mass index (BMI), smoking, drinking, hypertension, type 2 diabetes mellitus (T2DM), neoadjuvant therapy, LDH, albumin, hemoglobin, LAR, tumor location, tumor node metastasis (TNM) stage, and tumor size. This evidence concerns the gene ALB and type 2 diabetes mellitus.